Pavel Dostál

Dr. Pavel Dostál

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of Neurosurgical Anesthesiology
Verified
Journal Article
Closed access
PDPavel Dostál
Pavel Dostál
VDVlasta Dostalova
Vlasta Dostalova
JSJitka Schreiberova
Jitka Schreiberova
TTTomas Tyll
Tomas Tyll
JHJirina Habalova
Jirina Habalova
TČTomas Česak
Tomas Česak
Hyperosmolar solutions have been used in neurosurgery to modify brain bulk and prevent neurological deterioration. The purpose of the study was to compare the effects of equivolume, equiosmolar solutions of mannitol and hypertonic saline (HTS) on brain relaxation and postoperative complications in patients undergoing elective intracranial tumor surgery. In this prospective, randomized study, patients with American Society of Anesthesiologists physical status I to III scheduled to undergo a craniotomy for intracranial tumors were enrolled. Patients received a 3.75 mL/kg intravenous infusion of either 3.2% HTS (group HTS, n=36) or 20% mannitol (group M, n=38). The surgeon assessed the condition of the brain using a 4-point scale after opening the dura. Recorded measures included duration of surgery, blood loss, urine output, volume and type of infused fluids, hemodynamic variables, electrolytes, glucose, creatinine, predefined postoperative complications, and length of intensive care unit and hospital stays. Brain relaxation conditions in group HTS (score 1/2/3/4, n=10/17/2/7) were better than those in group M (score 1/2/3/4, n=3/18/3/14, P=0.0281). Patients in group M had higher urine output, received more crystalloids during surgery, and displayed lower central venous pressure and lower natremia at the end of surgery than did patients in group HTS. No significant differences in postoperative complications or lengths of intensive care unit and hospital stays were observed between the groups. Our results suggest that HTS provides better brain relaxation than mannitol during elective intracranial tumor surgery.

1 December 2019 in Minerva Anestesiologica
Verified
Journal Article
Closed access
VDVlasta Dostalova
Vlasta Dostalova
JSJitka Schreiberova
Jitka Schreiberova
MBMichael Bartos
Michael Bartos
LKLucie Kukralova
Lucie Kukralova
PDPavel Dostál
Pavel Dostál
The Surgical Plethysmographic Index (SPI) and the Analgesia Nociception Index (ANI) have been suggested for the non-invasive intraoperative monitoring of nociception/anti-nociception balance. We aimed to compare patterns of intraoperative use of opioids, postoperative cortisol levels and postoperative pain scores after intraoperative analgesia guided either by ANI, SPI or anesthesiologist's judgment. Seventy-two adult ASA I-III patients scheduled for elective neurosurgical spinal procedures were randomized into the ANI group, SPI group and control group. Anesthesia and intraoperative use of opioids (sufentanil boluses based on body weight) were managed according to a strict protocol. The use of sufentanil was targeted to keep ANI value 50-70 in the ANI group, SPI value below individual postinduction baseline value plus 10 points in the SPI group. In the control group, the use of opioids was left at anesthesiologist's discretion. Additional sufentanil boluses were administered earlier in the ANI and SPI groups in comparison to the control group (third dose after 51.8±22.1 vs. 52.7±14.8 vs. 84.5±24.8 min respectively, P=0.001; fourth dose after 61.3±30.1 vs. 57.2±14.1 vs. 120.0±26.2 min, P=0.003, and fifth dose after 78.8±33.7 vs. 74.0±11.6 vs. 146.7±23.2 min respectively, P=0.009). There were no differences in postoperative cortisol levels, time to spontaneous breathing at the end of anesthesia and postoperative pain scores. Both ANI and SPI guidance significantly modified intraoperative opioid use, but no modification of postoperative cortisol levels and postoperative pain was observed.

22 December 2010 in Critical Care
Verified
Journal Article
Open access
RŠRoman Škulec
Roman Škulec
ATAnatolij Truhlář
Anatolij Truhlář
JŠJana Šeblová
Jana Šeblová
PDPavel Dostál
Pavel Dostál
VCVladimír Cerný
Vladimír Cerný
Introduction: Pre-hospital induction of therapeutic mild hypothermia (TH) may reduce post-cardiac arrest brain injury in patients resuscitated from out-of-hospital cardiac arrest. Most often, it is induced by a rapid intravenous administration of as much as 30 ml/kg of cold crystalloids. We decided to assess the pre-hospital cooling effectivity of this approach by using a target dose of 15-20 ml/kg of 4°C cold normal saline in the setting of the physician-staffed Emergency Medical Service. The safety and impact on the clinical outcome have also been analyzed. Methods: We performed a prospective observational study with a retrospective control group. A total of 40 patients were cooled by an intravenous administration of 15-20 ml/kg of 4°C cold normal saline during transport to the hospital (TH group). The pre-hospital decrease of tympanic temperature (TT) was analyzed as the primary endpoint. Patients in the control group did not undergo any pre-hospital cooling. Results: In the TH group, administration of 12.6 ± 6.4 ml/kg of 4°C cold normal saline was followed by a pre-hospital decrease of TT of 1.4 ± 0.8°C in 42.8 ± 19.6 min (p < 0.001). The most effective cooling was associated with a transport time duration of 38-60 min and with an infusion of 17 ml/kg of cold saline. In the TH group, a trend toward a reduced need for catecholamines during transport was detected (35.0 vs. 52.5%, p = 0.115). There were no differences in demographic variables, comorbidities, parameters of the cardiopulmonary resuscitation and in other post-resuscitation characteristics. The coupling of pre-hospital cooling with subsequent in-hospital TH predicted a favorable neurological outcome at hospital discharge (OR 4.1, CI95% 1.1-18.2, p = 0.046). Conclusions: Pre-hospital induction of TH by the rapid intravenous administration of cold normal saline has been shown to be efficient even with a lower dose of coolant than reported in previous studies. This dose can be associated with a favorable impact on circulatory stability early after the return of spontaneous circulation and, when coupled with in-hospital continuation of cooling, can potentially improve the prognosis of patients. Trial Registration: ClinicalTrials (NCT): NCT00915421

30 June 2007 in Resuscitation
Verified
Journal Article
Closed access
ATAnatolij Truhlář
Anatolij Truhlář
VCVladimir Cerny
Vladimir Cerny
PDPavel Dostál
Pavel Dostál
MSMiroslav Solar
Miroslav Solar
RPRenata Parizkova
Renata Parizkova
LZLadislav Zabka
Ladislav Zabka

22 July 2019 in Clinical Hemorheology and Microcirculation
Verified
Journal Article
Closed access
PDF file
DADavid Astapenko
David Astapenko
VDVlasta Dostalova
Vlasta Dostalova
JKJaroslav Kraus
Jaroslav Kraus
VRVera Radochova
Vera Radochova
PDPavel Dostál
Pavel Dostál
VCVladimír Cerný
Vladimír Cerný
BACKGROUND AND OBJECTIVE: The endothelial glycocalyx (EG) is fragile and sensitive to damage such as exposure to hypernatremia. Our aim was to describe the influence of hypernatremia on the EG in sublingual and brain microcirculation in rabbits. METH

19 November 2018 in Trials
Verified
Journal Article
Open access
PDF file
MUMartin Unger
Martin Unger
AMAndrea Morelli
Andrea Morelli
MSMervyn Singer
Mervyn Singer
PRPeter Radermacher
Peter Radermacher
SRSebastian Rehberg
Sebastian Rehberg
GKGünther Krumpl
Günther Krumpl
In patients with septic shock, the presence of an elevated heart rate (HR) after fluid resuscitation marks a subgroup of patients with a particularly poor prognosis. Several studies have shown that HR control in this population is safe and can potentially improve outcomes. However, all were conducted in a single-center setting. The aim of this multicenter study is to demonstrate that administration of the highly beta1-selective and ultrashort-acting beta blocker landiolol in patients with septic shock and persistent tachycardia (HR ≥ 95 beats per minute [bpm]) is effective in reducing and maintaining HR without increasing vasopressor requirements. A phase IV, multicenter, prospective, randomized, open-label, controlled study is being conducted. The study will enroll a total of 200 patients with septic shock as defined by The Third International Consensus Definitions for Sepsis and Septic Shock criteria and tachycardia (HR ≥ 95 bpm) despite a hemodynamic optimization period of 24–36 h. Patients are randomized (1:1) to receive either standard treatment (according to the Surviving Sepsis Campaign Guidelines 2016) and continuous landiolol infusion to reach a target HR of 80–94 bpm or standard treatment alone. The primary endpoint is HR response (HR 80–94 bpm), the maintenance thereof, and the absence of increased vasopressor requirements during the first 24 h after initiating treatment. Despite recent studies, the role of beta blockers in the treatment of patients with septic shock remains unclear. This study will investigate whether HR control using landiolol is safe, feasible, and effective, and further enhance the understanding of beta blockade in patients with septic shock. EU Clinical Trials Register; EudraCT, 2017-002138-22 . Registered on 8 August 2017.